Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 10,180 $ 13,172
Other receivables 1,538 1,919
Inventory, net 0 20
Prepaid expenses and other current assets 940 1,290
Restricted cash, current portion 1 15
Total current assets 12,659 16,416
Property and equipment, net 2,071 2,411
Goodwill 14,409 14,409
Restricted cash, net of current portion 131 131
Total assets 29,270 33,367
Current liabilities:    
Accounts payable 789 2,882
Deferred revenue 0 88
Accrued expenses and other current liabilities 5,216 13,214
Notes payable, current 0 5,930
Total current liabilities 6,005 22,114
Notes payable, non-current 0 13,486
Royalty obligation 2,000 2,000
Deferred tax liability, net 164 141
Derivative liability 4,950 4,830
Other long-term liabilities 1,456 1,711
Total liabilities 14,575 44,282
Stockholders’ equity (deficit):    
Common stock—$0.001 par value; 200,000,000 shares authorized at September 30, 2023 and December 31, 2022; 192,382,419 and 9,430,535 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively 192 9
Additional paid-in capital 341,469 292,900
Accumulated deficit (326,966) (303,824)
Total stockholders’ equity (deficit) 14,695 (10,915)
Total liabilities and stockholders’ equity (deficit) $ 29,270 $ 33,367